It looks like the eVU financing is structured for at least 3 years...
``...pay the purchasers (in the aggregate) a royalty as consideration for the additional financing necessary for the development of the company`s new eVU(TM)(formerly known as MedeViewer) product equal to up to Twenty Dollars ($20.00) for each eVU(TM) sold for a period of three years (the ``Royalty``).
And in late February they banked $1.5 million from the sale of some restricted stock financing, of which two of the financiers are officers of the company.
And from the sounds of things their monthly nut just got smaller.
And now eVU sales with larger margins than on the previous IFE offering...
They sold something !!!! They ought to try that again.
